Calzas C, Alkie T, Suderman M, Embury-Hyatt C, Khatri V, Le Goffic R
NPJ Vaccines. 2024; 9(1):161.
PMID: 39237609
PMC: 11377767.
DOI: 10.1038/s41541-024-00944-7.
Wang H, Tian J, Zhao J, Zhao Y, Yang H, Zhang G
Vaccines (Basel). 2024; 12(6).
PMID: 38932359
PMC: 11209050.
DOI: 10.3390/vaccines12060630.
Sun Z, Wang Q, Li G, Li J, Chen S, Qin T
Microbiol Spectr. 2021; 9(2):e0068721.
PMID: 34585985
PMC: 8557892.
DOI: 10.1128/Spectrum.00687-21.
El-Moeid A, El-Deeb A, Elsaied M, Soliman R, El-Safty M, Hussein H
Vet World. 2021; 14(8):2131-2141.
PMID: 34566331
PMC: 8448630.
DOI: 10.14202/vetworld.2021.2131-2141.
Saikia D, Yadav K, Pathak D, Ramamurthy N, Dsilva A, Marriappan A
Pathogens. 2019; 8(3).
PMID: 31510020
PMC: 6789743.
DOI: 10.3390/pathogens8030145.
Viral vector-based influenza vaccines.
de Vries R, Rimmelzwaan G
Hum Vaccin Immunother. 2016; 12(11):2881-2901.
PMID: 27455345
PMC: 5137548.
DOI: 10.1080/21645515.2016.1210729.
Assessment of the safety and efficacy of low pathogenic avian influenza (H9N2) virus in inactivated oil emulsion vaccine in laying hens.
Shin J, Mo J, Kim J, Mo I, Ha B
J Vet Sci. 2016; 17(1):27-34.
PMID: 27051337
PMC: 4808641.
DOI: 10.4142/jvs.2016.17.1.27.
The evolution of poxvirus vaccines.
Sanchez-Sampedro L, Perdiguero B, Mejias-Perez E, Garcia-Arriaza J, Di Pilato M, Esteban M
Viruses. 2015; 7(4):1726-803.
PMID: 25853483
PMC: 4411676.
DOI: 10.3390/v7041726.
Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
Swayne D, Suarez D, Spackman E, Jadhao S, Dauphin G, Kim-Torchetti M
J Virol. 2015; 89(7):3746-62.
PMID: 25609805
PMC: 4403412.
DOI: 10.1128/JVI.00025-15.
Construction of recombinant Marek's disease virus (rMDV) co-expressing AIV-H9N2-NA and NDV-F genes under control of MDV's own bi-directional promoter.
Zhang Z, Ma C, Zhao P, Duan L, Chen W, Zhang F
PLoS One. 2014; 9(3):e90677.
PMID: 24599338
PMC: 3944216.
DOI: 10.1371/journal.pone.0090677.
Genetic and antigenic analysis of H5N1 viruses for selection of HA-donor virus for vaccine strains.
Bhatia S, Kunal A, Khandia R, Siddiqui A, Pateriya A, Sood R
Indian J Virol. 2014; 24(3):357-64.
PMID: 24426298
PMC: 3832698.
DOI: 10.1007/s13337-013-0151-2.
Clinical features and factors associated with outcomes of patients infected with a Novel Influenza A (H7N9) virus: a preliminary study.
Chen X, Yang Z, Lu Y, Xu Q, Wang Q, Chen L
PLoS One. 2013; 8(9):e73362.
PMID: 24069191
PMC: 3775774.
DOI: 10.1371/journal.pone.0073362.
Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: pathobiology and vaccine protection.
Kapczynski D, Pantin-Jackwood M, Guzman S, Ricardez Y, Spackman E, Bertran K
J Virol. 2013; 87(16):9086-96.
PMID: 23760232
PMC: 3754080.
DOI: 10.1128/JVI.00666-13.
Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.
Cui H, Gao H, Cui X, Zhao Y, Shi X, Li Q
PLoS One. 2013; 8(1):e53340.
PMID: 23301062
PMC: 3536743.
DOI: 10.1371/journal.pone.0053340.
Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus.
Chua T, Leung C, Fang H, Chow C, Ma S, Sia S
Influenza Res Treat. 2012; 2010:489213.
PMID: 23074648
PMC: 3447282.
DOI: 10.1155/2010/489213.
Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses.
Nang N, Song B, Kang Y, Kim H, Kim H, Seo S
Influenza Other Respir Viruses. 2012; 7(2):120-31.
PMID: 22487301
PMC: 5780756.
DOI: 10.1111/j.1750-2659.2012.00363.x.
Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.
Singh S, Toro H, Tang D, Briles W, Yates L, Kopulos R
Virology. 2010; 405(1):62-9.
PMID: 20557918
PMC: 2930022.
DOI: 10.1016/j.virol.2010.05.002.
Characterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus.
Hghihghi H, Read L, Mohammadi H, Pei Y, Ursprung C, Nagy E
Clin Vaccine Immunol. 2010; 17(3):454-63.
PMID: 20071494
PMC: 2837961.
DOI: 10.1128/CVI.00487-09.
Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.
Haghighi H, Read L, Haeryfar S, Behboudi S, Sharif S
PLoS One. 2009; 4(11):e7772.
PMID: 19901990
PMC: 2770124.
DOI: 10.1371/journal.pone.0007772.
Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.
Nayak B, Rout S, Kumar S, Khalil M, Fouda M, Ahmed L
PLoS One. 2009; 4(8):e6509.
PMID: 19654873
PMC: 2716524.
DOI: 10.1371/journal.pone.0006509.